Blue Water Vaccines Inc

Company Profile

Blue Water Vaccines Inc had its IPO on 2022-02-18 under the ticker symbol BWV.

The company operates in the Healthcare sector and Biotechnology industry. Blue Water Vaccines Inc has a staff strength of 12 employees.

Stock update

Shares of Blue Water Vaccines Inc opened at $0.68 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.68 - $0.72, and closed at $0.68.

This is a +0.15% increase from the previous day's closing price.

A total volume of 43,723 shares were traded at the close of the day’s session.

In the last one week, shares of Blue Water Vaccines Inc have slipped by -10.37%.

Blue Water Vaccines Inc's Key Ratios

Blue Water Vaccines Inc has a market cap of $12.69 million, indicating a price to book ratio of 0.7157 and a price to sales ratio of 0.

In the last 12-months Blue Water Vaccines Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-13474488. The EBITDA ratio measures Blue Water Vaccines Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Blue Water Vaccines Inc’s operating margin was 0% while its return on assets stood at -57.33% with a return of equity of -112.61%.

In Q1, Blue Water Vaccines Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Blue Water Vaccines Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.9 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Blue Water Vaccines Inc’s profitability.

Blue Water Vaccines Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0.9378. Its price to sales ratio in the trailing 12-months stood at 0.

Blue Water Vaccines Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$22.50 million

Total Liabilities

$2.81 million

Operating Cash Flow

$0

Capital Expenditure

$1819

Dividend Payout Ratio

0%

Blue Water Vaccines Inc ended 2024 with $22.50 million in total assets and $0 in total liabilities. Its intangible assets were valued at $22.50 million while shareholder equity stood at $19.69 million.

Blue Water Vaccines Inc ended 2024 with $0 in deferred long-term liabilities, $2.81 million in other current liabilities, 164.00 in common stock, $-22223144.00 in retained earnings and $0 in goodwill. Its cash balance stood at $20.26 million and cash and short-term investments were $20.26 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

Blue Water Vaccines Inc’s total current assets stands at $22.47 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $70302.00 compared to accounts payable of $1.50 million and inventory worth $0.

In 2024, Blue Water Vaccines Inc's operating cash flow was $0 while its capital expenditure stood at $1819.

Comparatively, Blue Water Vaccines Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.68

52-Week High

$8

52-Week Low

$0.731

Analyst Target Price

$6.5

Blue Water Vaccines Inc stock is currently trading at $0.68 per share. It touched a 52-week high of $8 and a 52-week low of $8. Analysts tracking the stock have a 12-month average target price of $6.5.

Its 50-day moving average was $0.98 and 200-day moving average was $1.08 The short ratio stood at 2.41 indicating a short percent outstanding of 0%.

Around 2538.2% of the company’s stock are held by insiders while 1724.5% are held by institutions.